In the first of this six-part series, Mark Andrews puts Xpeng’s G6 sports-utility vehicle through the paces, concluding that it is not so much a car that you drive than the car that drives you.

The XPeng G6 is far more than a Tesla Model Y clone. It’s an existential threat to conventional premium SUVs So swiftly and smoothly does the XPeng G6 park itself after a few taps on the touchscreen, ...

In what makes Abbott Laboratories a serious competitor is the much lower price one has to pay for FreeStyle Libre - in comparison to Dexcom's G6 (or G7) and also in comparison to Medtronic's Guardian.

An internal leak has revealed the company's projected benchmarks for the upcoming Tensor G5 and G6 chips, which are expected to power the Pixel 10 and Pixel 11 lineups, respectively. In terms of ...

Amid the launch of its first over-the-counter wearable glucose tracker, Dexcom reported that its overall revenues in the U.S. declined year over year despite overall sales coming in slightly ...

Its products include DexCom G4 PLATINUM System, DexCom G5 Mobil, DexCom G6, and DexCom Share. Read More on DXCM: DexCom NewsMORE Related Stocks Indices ...

Its products include DexCom G4 PLATINUM System, DexCom G5 Mobil, DexCom G6, and DexCom Share. Read More on DXCM: DexCom NewsMORE Related Stocks Indices Commodities ...

DexCom (DXCM) reported $994.2 million in revenue for the quarter ended September 2024, representing a year-over-year increase of 2%. EPS of $0.45 for the same period compares to $0.50 a year ago.

The Tensor G5 is supposed by the same Arm Cortex-X4 that is runs the Tensor G4. Apparently, the Tensor G6, which will feature in the Pixel 11, gets rid of efficiency cores in favor of a new ...

Dexcom Chief Commercial Officer Teri Lawver will leave the company as it grapples with challenges following a sales restructuring. Lawver joined the company in January 2023 for the newly created ...

Oct 24 (Reuters) - Medical device maker Dexcom (DXCM.O), opens new tab beat Wall Street estimates for third-quarter revenue and profit on Thursday, helped by resilient demand for its continuous ...

Shares of Dexcom (NASDAQ:DXCM) fell 16% in post-market trading Thursday after the company released its Q3 earnings report which showed only modest topline growth over last year’s quarter.